Chad Slawson

Chad Slawson is Professor in the Department of Biochemistry and Molecular Biology at the University of Kansas Medical Center. His research focuses on O-GlcNAcylation, a dynamic post-translational modification that regulates cellular processes such as nutrient sensing, stress response, and mitochondrial function.

Dr. Slawson's laboratory has made significant contributions to understanding how O-GlcNAc modifies proteins in the

• Mitochondria
• Nucleus
• Cytoplasm

to affect disease mechanisms including cancer and Alzheimer's.

His work has been funded by major organizations including

• National Institutes of Health (NIH)
• Midwest Cancer Alliance
• Patton Trust

and he maintains active professional affiliations with

• American Society for Biochemistry and Molecular Biology (ASBMB)
• American Chemical Society (ACS)

Recent publication trends show Dr. Slawson's expanding impact across

• Neurodegenerative disease mechanisms
• Cancer metabolism
• Immunometabolism
• Transcriptional regulation
• Mitochondrial stress response
• Metabolic disease pathways

His laboratory has developed novel CRISPR-based tools for studying O-GlcNAc regulation at genomic cis-regulatory elements, advancing epigenetic research methodologies.